- Home
- POCI vs BOLD Comparison
POCI vs BOLD Comparison
Compare POCI & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POCI
- BOLD
- Stock Information
- Founded
- POCI 1982
- BOLD 2018
- Country
- POCI United States
- BOLD United States
- Employees
- POCI N/A
- BOLD N/A
- Industry
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BOLD
- Sector
- POCI Health Care
- BOLD
- Exchange
- POCI Nasdaq
- BOLD Nasdaq
- Market Cap
- POCI 35.1M
- BOLD 30.3M
- IPO Year
- POCI N/A
- BOLD 2024
- Fundamental
- Price
- POCI $4.73
- BOLD $1.04
- Analyst Decision
- POCI
- BOLD Buy
- Analyst Count
- POCI 0
- BOLD 3
- Target Price
- POCI N/A
- BOLD $4.00
- AVG Volume (30 Days)
- POCI 19.0K
- BOLD 359.3K
- Earning Date
- POCI 05-15-2025
- BOLD 08-11-2025
- Dividend Yield
- POCI N/A
- BOLD N/A
- EPS Growth
- POCI N/A
- BOLD N/A
- EPS
- POCI N/A
- BOLD N/A
- Revenue
- POCI $17,626,155.00
- BOLD N/A
- Revenue This Year
- POCI N/A
- BOLD N/A
- Revenue Next Year
- POCI N/A
- BOLD N/A
- P/E Ratio
- POCI N/A
- BOLD N/A
- Revenue Growth
- POCI N/A
- BOLD N/A
- 52 Week Low
- POCI $3.47
- BOLD $1.00
- 52 Week High
- POCI $6.59
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- POCI 56.28
- BOLD N/A
- Support Level
- POCI $4.43
- BOLD N/A
- Resistance Level
- POCI $5.00
- BOLD N/A
- Average True Range (ATR)
- POCI 0.34
- BOLD 0.00
- MACD
- POCI 0.01
- BOLD 0.00
- Stochastic Oscillator
- POCI 77.01
- BOLD 0.00
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.